HomeCompareHNGZY vs GBDC

HNGZY vs GBDC: Dividend Comparison 2026

HNGZY yields 0.72% · GBDC yields 11.85%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GBDC wins by $19.10M in total portfolio value
10 years
HNGZY
HNGZY
● Live price
0.72%
Share price
$4.00
Annual div
$0.03
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.68M
Annual income
$1,324,338.59
Full HNGZY calculator →
GBDC
GBDC
● Live price
11.85%
Share price
$12.66
Annual div
$1.50
5Y div CAGR
51.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.78M
Annual income
$16,389,263.41
Full GBDC calculator →

Portfolio growth — HNGZY vs GBDC

📍 GBDC pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHNGZYGBDC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HNGZY + GBDC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
HNGZY pays
GBDC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HNGZY
Annual income on $10K today (after 15% tax)
$61.54/yr
After 10yr DRIP, annual income (after tax)
$1,125,687.80/yr
GBDC
Annual income on $10K today (after 15% tax)
$1,007.11/yr
After 10yr DRIP, annual income (after tax)
$13,930,873.90/yr
At 15% tax rate, GBDC beats the other by $12,805,186.10/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HNGZY + GBDC for your $10,000?

HNGZY: 50%GBDC: 50%
100% GBDC50/50100% HNGZY
Portfolio after 10yr
$11.23M
Annual income
$8,856,800.99/yr
Blended yield
78.90%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on GBDC right now

HNGZY
No analyst data
Altman Z
7.2
Piotroski
7/9
GBDC
Analyst Ratings
6
Buy
5
Hold
Consensus: Buy
Price Target
$14.00
+10.6% upside vs current
Range: $13.00 — $15.00
Altman Z
0.6
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HNGZY buys
0
GBDC buys
0
No recent congressional trades found for HNGZY or GBDC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHNGZYGBDC
Forward yield0.72%11.85%
Annual dividend / share$0.03$1.50
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%51.1%
Portfolio after 10y$1.68M$20.78M
Annual income after 10y$1,324,338.59$16,389,263.41
Total dividends collected$1.62M$20.36M
Payment frequencyquarterlyquarterly
SectorStockBDC

Year-by-year: HNGZY vs GBDC ($10,000, DRIP)

YearHNGZY PortfolioHNGZY Income/yrGBDC PortfolioGBDC Income/yrGap
1← crossover$10,845$144.81$12,490$1,790.28$1.6KGBDC
2$11,897$293.53$16,522$3,157.73$4.6KGBDC
3$13,332$601.91$23,578$5,898.68$10.2KGBDC
4$15,526$1,260.74$37,115$11,886.75$21.6KGBDC
5$19,357$2,744.31$66,136$26,423.57$46.8KGBDC
6$27,108$6,395.29$137,257$66,491.44$110.1KGBDC
7$45,745$16,739.89$341,734$194,868.54$296.0KGBDC
8$101,749$52,802.12$1,050,788$685,133.02$949.0KGBDC
9$328,397$219,525.46$4,099,314$2,974,971.01$3.77MGBDC
10$1,675,724$1,324,338.59$20,775,530$16,389,263.41$19.10MGBDC

HNGZY vs GBDC: Complete Analysis 2026

HNGZYStock

Hangzhou Tigermed Consulting Co., Ltd. provides contract research organization services in the People's Republic of China and internationally. It operates in Clinical Trial Solutions, and Clinical-related and Laboratory Services segments. The company offers regulatory submission and approval, medical translation, and good manufacturing practice (GMP) consulting services; and clinical services in the areas of medical science, early clinical and late phase development, medical monitoring, project management, patient recruitment, and quality management system. It also provides biometrics services comprising data management, biostatistics, and statistical programming; and integrated technology services, such as site management, pharmacovigilance, third party audit and training, medical imaging, clinical trial system solution, central laboratory, pre-clinical, and research hospital. Further, the company offers medical device/ in vitro diagnostics (IVD) services comprising medical device testing, regulatory submission, clinical evaluation and trials, GMP certificate, EU MDR and IVDR preparation, and value-added services; and post-marketing study, real world evidence, and vaccine clinical trial services. Hangzhou Tigermed Consulting Co., Ltd. was incorporated in 2004 and is headquartered in Hangzhou, the People's Republic of China.

Full HNGZY Calculator →

GBDCBDC

Golub Capital BDC, Inc. (GBDC) is a business development company and operates as an externally managed closed-end non-diversified management investment company. It invests in debt and minority equity investments in middle-market companies that are, in most cases, sponsored by private equity investors. It typically invests in diversified consumer services, automobiles, healthcare technology, insurance, health care equipment and supplies, hotels, restaurants and leisure, healthcare providers and services, IT services and specialty retails. It seeks to invest in the United States. It primarily invests in first lien traditional senior debt, first lien one stop, junior debt and equity, senior secured, one stop, unitranche, second lien, subordinated and mezzanine loans of middle-market companies, and warrants.

Full GBDC Calculator →
📬

Get this HNGZY vs GBDC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HNGZY vs SCHDHNGZY vs JEPIHNGZY vs OHNGZY vs KOHNGZY vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.